obesity

Ahmedabad, March 21: Torrent Pharmaceuticals has launched Semaglutide brands - Sembolic and Semalix - in India, expanding the company’s presence in metabolic disorders such as type-2 diabetes and obesity. These medicines will be available…
Read More...